Evaluation of the effects of a lotion containing Althaea officinalis, Ocimum basilicum, and Apium graveolensin extracts in the prevention and treatment of radiation therapy-induced dermatitis in breast cancer patients: A Placebo-Controlled, Double-Blind, Randomized Clinical Trial

Mashhad University of Medical Sciences0 个研究点目标入组 72 人开始时间: 待定最近更新: 2023年10月16日

适应症

试验速览

暂无简介。

•patients (women) >18 years, undergone breast Lumpectomy surgery for breast cancer and a fractionation regimen of at least 42 Gy.
•Patients capable of finishing radiotherapy and contributing to the research team.
•The patient is personally capable of lotion application and learning the research instructions.
•Patient who have not undergone radiotherapy previously.

•Patients with ulcers or unhealed wounds, burns, infections, and previous skin complications at the radiotherapy site.
•Patients who undergo chemotherapy or hormone therapy (adjuvant or neoadjuvant) at the same time
•Using skin medicines to treat skin diseases other than dermatitis caused by radiation therapy
•Patients taking high-dose non-steroidal anti-inflammatory drugs.
•Presence of connective tissue disorders or collagen disorders
•Allergy to the herbs used in the intervention lotion or any of the components of the formulation
•Allergy to the routine treatment used in the treatment of dermatitis
•underlying disease such as diabetes
•Taking radiation sensitizing drugs

发起方